Searched over 200M research papers
10 papers analyzed
These studies suggest that lifestyle modifications and metformin are effective in preventing the progression of pre-diabetes to type 2 diabetes, while JinQi-Jiangtang tablets show potential benefits.
20 papers analyzed
Pre-diabetes is a metabolic condition characterized by blood glucose levels that are higher than normal but not high enough to be classified as diabetes. It is diagnosed through impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and elevated glycosylated hemoglobin (HbA1c) levels. The condition is highly prevalent, especially among older adults and obese individuals.
Early detection of pre-diabetes is crucial as it significantly increases the risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). Up to 70% of individuals with pre-diabetes may progress to diabetes over their lifetime, making early intervention essential. Effective management strategies can prevent or delay the onset of diabetes and reduce associated complications.
Lifestyle modifications are the cornerstone of pre-diabetes management. These include dietary changes, increased physical activity, and weight loss. Studies have shown that lifestyle interventions can significantly reduce the risk of progressing to diabetes by improving various health parameters such as body mass index (BMI), blood glucose levels, and blood pressure . One-to-one consultations focusing on reducing carbohydrate intake have also been effective in improving pre-diabetes.
While lifestyle modifications are highly effective, pharmacological interventions can also play a crucial role in managing pre-diabetes. Metformin is the most studied and widely recommended medication for pre-diabetes, showing long-term safety and efficacy in preventing the progression to diabetes. Other medications like GLP-1 receptor agonists and thiazolidinediones have also shown promise, although more research is needed to establish their long-term benefits .
In addition to conventional medications, traditional medicines like the JinQi-Jiangtang (JQJT) tablets have been studied for their potential benefits in managing pre-diabetes. A randomized controlled trial in China is currently evaluating the effectiveness and safety of JQJT tablets, with promising preliminary results.
Despite the availability of effective interventions, several barriers hinder the management of pre-diabetes. These include knowledge deficits, poor behavior towards lifestyle changes, and limited access to resources and support systems. Addressing these barriers through education, practical skills training, and improved accessibility to lifestyle management programs is essential for effective pre-diabetes management.
Pre-diabetes is a critical condition that requires timely and effective management to prevent the progression to diabetes and associated complications. Lifestyle modifications remain the first line of defense, but pharmacological interventions like metformin and traditional medicines like JQJT tablets also offer promising results. Overcoming barriers to effective management through education and resource provision is crucial for improving outcomes in individuals with pre-diabetes.
Most relevant research papers on this topic